Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Evidences for Cooperative Resonance-Assisted Hydrogen Bonds in Protein Secondary Structure Analogs.

Zhou Y, Deng G, Zheng YZ, Xu J, Ashraf H, Yu ZW.

Sci Rep. 2016 Nov 16;6:36932. doi: 10.1038/srep36932.

PMID:
27849028
2.

Copper and Zinc Interactions with Cellular Prion Proteins Change Solubility of Full-Length Glycosylated Isoforms and Induce the Occurrence of Heterogeneous Phenotypes.

Brim S, Groschup MH, Kuczius T.

PLoS One. 2016 Apr 19;11(4):e0153931. doi: 10.1371/journal.pone.0153931.

PMID:
27093554
3.

Spectroscopic and Theoretical Study of Cu(I) Binding to His111 in the Human Prion Protein Fragment 106-115.

Arcos-López T, Qayyum M, Rivillas-Acevedo L, Miotto MC, Grande-Aztatzi R, Fernández CO, Hedman B, Hodgson KO, Vela A, Solomon EI, Quintanar L.

Inorg Chem. 2016 Mar 21;55(6):2909-22. doi: 10.1021/acs.inorgchem.5b02794.

PMID:
26930130
4.

Insight into Early-Stage Unfolding of GPI-Anchored Human Prion Protein.

Wu EL, Qi Y, Park S, Mallajosyula SS, MacKerell AD Jr, Klauda JB, Im W.

Biophys J. 2015 Nov 17;109(10):2090-100. doi: 10.1016/j.bpj.2015.10.009.

PMID:
26588568
5.

Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.

Katorcha E, Makarava N, Savtchenko R, Baskakov IV.

Sci Rep. 2015 Nov 18;5:16912. doi: 10.1038/srep16912.

PMID:
26576925
6.

Contributions of the Prion Protein Sequence, Strain, and Environment to the Species Barrier.

Sharma A, Bruce KL, Chen B, Gyoneva S, Behrens SH, Bommarius AS, Chernoff YO.

J Biol Chem. 2016 Jan 15;291(3):1277-88. doi: 10.1074/jbc.M115.684100.

PMID:
26565023
7.

Two alternative pathways for generating transmissible prion disease de novo.

Makarava N, Savtchenko R, Baskakov IV.

Acta Neuropathol Commun. 2015 Nov 10;3:69. doi: 10.1186/s40478-015-0248-5.

PMID:
26556038
8.

Efficient PRNP deletion in bovine genome using gene-editing technologies in bovine cells.

Choi W, Kim E, Yum SY, Lee C, Lee J, Moon J, Ramachandra S, Malaweera BO, Cho J, Kim JS, Kim S, Jang G.

Prion. 2015;9(4):278-91. doi: 10.1080/19336896.2015.1071459.

PMID:
26217959
9.

Removal of transmissible spongiform encephalopathy prion from large volumes of cell culture media supplemented with fetal bovine serum by using hollow fiber anion-exchange membrane chromatography.

Chou ML, Bailey A, Avory T, Tanimoto J, Burnouf T.

PLoS One. 2015 Apr 13;10(4):e0122300. doi: 10.1371/journal.pone.0122300.

PMID:
25874629
10.

Human prion protein sequence elements impede cross-species chronic wasting disease transmission.

Kurt TD, Jiang L, Fernández-Borges N, Bett C, Liu J, Yang T, Spraker TR, Castilla J, Eisenberg D, Kong Q, Sigurdson CJ.

J Clin Invest. 2015 Apr;125(4):1485-96. doi: 10.1172/JCI79408. Erratum in: J Clin Invest. 2015 Jun;125(6):2548. J Clin Invest. 2015 Apr;125(4):doi:10.1172/JCI82647..

PMID:
25705888
12.

Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.

Kim DH, Lee HM, Ryou C.

J Korean Med Sci. 2014 Dec;29(12):1604-9. doi: 10.3346/jkms.2014.29.12.1604.

PMID:
25469058
13.

Prion fragment peptides are digested with membrane type matrix metalloproteinases and acquire enzyme resistance through Cu²⁺-binding.

Kojima A, Konishi M, Akizawa T.

Biomolecules. 2014 May 8;4(2):510-26. doi: 10.3390/biom4020510.

PMID:
24970228
14.

Solvent microenvironments and copper binding alters the conformation and toxicity of a prion fragment.

Inayathullah M, Satheeshkumar KS, Malkovskiy AV, Carre AL, Sivanesan S, Hardesty JO, Rajadas J.

PLoS One. 2013 Dec 27;8(12):e85160. doi: 10.1371/journal.pone.0085160.

PMID:
24386462
15.

Laboratory activities involving transmissible spongiform encephalopathy causing agents: risk assessment and biosafety recommendations in Belgium.

Leunda A, Van Vaerenbergh B, Baldo A, Roels S, Herman P.

Prion. 2013 Sep-Oct;7(5):420-33. doi: 10.4161/pri.26533. Review.

PMID:
24055928
16.

Quantum dots and prion proteins: is this a new challenge for neurodegenerative diseases imaging?

Sobrova P, Blazkova I, Chomoucka J, Drbohlavova J, Vaculovicova M, Kopel P, Hubalek J, Kizek R, Adam V.

Prion. 2013 Sep-Oct;7(5):349-58. doi: 10.4161/pri.26524. Review.

PMID:
24055838
17.

Age-dependent impairment of eyeblink conditioning in prion protein-deficient mice.

Kishimoto Y, Hirono M, Atarashi R, Sakaguchi S, Yoshioka T, Katamine S, Kirino Y.

PLoS One. 2013 Apr 10;8(4):e60627. doi: 10.1371/journal.pone.0060627.

PMID:
23593266
18.

Zinc drives a tertiary fold in the prion protein with familial disease mutation sites at the interface.

Spevacek AR, Evans EG, Miller JL, Meyer HC, Pelton JG, Millhauser GL.

Structure. 2013 Feb 5;21(2):236-46. doi: 10.1016/j.str.2012.12.002.

PMID:
23290724
19.

Kinetic studies of inhibition of the amyloid beta (1-42) aggregation using a ferrocene-tagged β-sheet breaker peptide.

Zhang L, Yagnik G, Peng Y, Wang J, Xu HH, Hao Y, Liu YN, Zhou F.

Anal Biochem. 2013 Mar 15;434(2):292-9. doi: 10.1016/j.ab.2012.11.025.

PMID:
23232068
20.

The cellular form of the prion protein is involved in controlling cell cycle dynamics, self-renewal, and the fate of human embryonic stem cell differentiation.

Lee YJ, Baskakov IV.

J Neurochem. 2013 Feb;124(3):310-22. doi: 10.1111/j.1471-4159.2012.07913.x.

PMID:
22860629
Items per page

Supplemental Content

Support Center